Диссертация (1139535), страница 51
Текст из файла (страница 51)
Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesiumsulfate and other anticonvulsants for women with preeclampsia. CochraneDatabase of Systematic Reviews, 2010, (11): CD000025.105. Duley L. The global impact of pre-eclampsia and eclampsia. SeminPerinatol. 2009 Jun;33(3):130-7; Ghulmiyyah L, Sibai B. Maternal mortality frompreeclampsia/eclampsia. Semin Perinatol. 2012 Feb; 36(1): 56-9.106.
Easterling TR. Pharmacological management of hypertension in pregnancy.Semin Perinatol. 2014 Oct 10. pii: S0146-0005(14)00104-9.107. Eiland E., Nzerue C., Faulkner M. Preeclampsia 2012. J Pregnancy. 2012;2012: 586578.108. Enquobahrie D.A., Abetew D.F., Sorensen T.K., Willoughby D.,Chidambaram K., Williams M.A. Placental microRNA expression in pregnanciescomplicated by preeclampsia. Am.
J. Obstet. Gynecol. 2011;204:178.e12–178.e21.109. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP,Kikkawa Y, Miner JH, Quaggin SE. Glomerular-specific alterations of VEGF-Aexpression lead to distinct congenital and acquired renal diseases. J Clin Invest.2003 Mar;111(5):707-16.110.
Ertl R, Yu CKH, Samaha R, Akolekar R, Nicolaides KH. Maternal serumvitamin D at 11–13 weeks in pregnancies delivering small for gestational ageneonates. Fetal Diagn Ther. 2012;31:103–108.111. Eshkoli T, Holcberg G, Bronfenmacher B, Amash A, Huleihel M, Erez O.Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal sideof placenta of women with preeclampsia.
J Matern Fetal Neonatal Med. 2013Jan;26(2):116-22.321112. Espinoza J, Espinoza AF, Power GG. High fetal plasma adenosineconcentration: a role for the fetus in preeclampsia? Am J Obstet Gynecol 2011;205: 485.e24–27.113. Espinoza J, Espinoza AF. Pre-eclampsia: a maternal manifestation of a fetaladaptive response? Ultrasound Obstet Gynecol 2011; 38: 367–370.114. Espinoza J, Kusanovic JP, Bahado-Singh R, Gervasi MT, Romero R, Lee W,Vaisbuch E, Mazaki-Tovi S, Mittal P, Gotsch F, Erez O, Gomez R, Yeo L, HassanSS. Should bilateral uterine artery notching be used in the risk assessment forpreeclampsia, small-forgestational-age, and gestational hypertension? J UltrasoundMed 2010; 29: 1103–1115.115. Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM.Angiogenic imbalances: the obstetric perspective.
Am J Obstet Gynecol 2010; 203:17–18.116. Espinoza J. Uteroplacental ischemia in early- and late-onset pre-eclampsia: arole for the fetus? Ultrasound Obstet Gynecol. 2012 Oct;40(4):372-82.117. Esplin M.S., Fausett M.B., Fraser A., Kerber R, Mineau G, Carrillo J,Varner MW. Paternal and maternal components of the predisposition topreeclampsia. N. Engl. J. Med. 2001;344:867–872.118. Evans CS, Gooch L, Flotta D, Lykins D, Powers RW, Landsittel D, RobertsJM, Shroff SG. Cardiovascular system during the postpartum state in women witha history of preeclampsia. Hypertension. 2011 Jul;58(1): 57-62.119.
Fayers S, Moodley J, Naidoo DP. Cardiovascular haemodynamics in preeclampsia using brain naturetic peptide and tissue Doppler studies. Cardiovasc JAfr. 2013 May;24(4):130-6.120. Feinberg BB. Preeclampsia: the Death of Goliath. Am J Reprod Immunol.2006 Feb;55(2):84-98.121. Feldt-Rasmussen U, Mathiesen ER. Endocrine disorders in pregnancy:physiological and hormonal aspects of pregnancy.
Best Pract Res Clin EndocrinolMetab. 2011; 25: 875–884.322122. Ferreira AF, Rezende JC, de Cassia C, Oliveira R, Akolekar R, NicolaidesKH. Maternal serum visfatin at 11–13 weeks’ gestation in preeclampsia. J HumHypertens. 2013;27:261–264.123. Fisher SJ. Why is placentation abnormal in preeclampsia? Am J ObstetGynecol. 2015 Oct;213(4 Suppl):S115-22.124.
Foidart JM, Munaut C, Chantraine F, Akolekar R, Nicolaides KH. Maternalplasma soluble endoglin at 11-13 weeksв gestation in pre-eclampsia. UltrasoundObstet Gynecol. 2010 Jun;35(6):680-687.125. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulationof anti-angiogenic agents (sFlt-1, PIGF, and sEndoglin) in preeclampsia - a stepforward but not the definitive answer. J Reprod Immunol.
2009 Nov;82(2):10611, Kingdom JC, Drewlo S. Is heparin a placental anticoagulant in high-riskpregnancies? Blood. 2011 Nov 3; 118(18): 4780-8.126. Freeman DJ, McManus F, Brown EA, et al. Short- and long-term changes inplasma inflammatory markers associated with preeclampsia. Hypertension.2004;44(5):708–714.127. Friedman AM, Cleary KL. Prediction and prevention of ischemic placentaldisease.
Semin Perinatol. 2014 Apr;38(3):177-182.128. Fu G, Brkić J, Hayder H, Peng C MicroRNAs in Human PlacentalDevelopment and Pregnancy Complications. Int J Mol Sci. 2013 Mar8;14(3):5519-44.129. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in therelaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov27;288(5789):373-6.130.
Gallery ED, Györy AZ. Immunoglobulin deposition in the kidney in preeclampsia: its significance. Aust N Z J Med. 1978 Aug;8(4):408-12.131. George EM, Granger JP. Endothelin: key mediator of hypertension inpreeclampsia. Am J Hypertens. 2011 Sep;24(9):964-9.132. Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiralarteries in the placental bed in relation to preeclampsia and fetal growth323retardation.
Br J Obstet Gynaecol. 1981; 88: 876–881.133. Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. Is serum placentalgrowth factor more effective as a biomarker in predicting early onset preeclampsiain early second trimester than in first trimester of pregnancy? Arch GynecolObstet. 2013;287:865–873.134.
Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia.Semin Perinatol. 2012 Feb; 36(1): 56-9.135. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduceduterine perfusion in pregnant rats is associated with increased soluble fms-liketyrosine kinase-1 expression. Hypertension 2007; 50: 1142–1147.136. Gilbert JS, Gilbert SA, Arany M, Granger JP.
Hypertension produced byplacental ischemia in pregnant rats is associated with increased soluble endoglinexpression. Hypertension 2009; 53: 399–403.137. Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO.Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation bycombining maternal characteristics and serum analytes, PAPP-A and free betahCG.
Prenat Diagn. 2010 Dec;30(12–13):1138-1142.138. Golombeck SK, Wessig C, Monoranu CM, Schütz A, Solymosi L, MelzerN, Kleinschnitz C. Fatal atypical reversible posterior leukoencephalopathysyndrome: a case report. J Med Case Rep. 2013 Jan 10;7(1):14.139. Goswami D., Tannetta D.S., Magee L.A., Fuchisawa A., Redman C.W.,Sargent I.L., von Dadelszen P. Excess syncytiotrophoblast microparticle sheddingis a feature of early-onset pre-eclampsia, but not normotensive intrauterine growthrestriction.
Placenta 2006 Jan;27(1):56-61.140. Gris JC, Chauleur C, Molinari N, Marès P, Fabbro-Peray P, Quéré I et al.Addition of enoxaparin to aspirin for the secondary prevention of placentalvascular complications in women with severe pre-eclampsia. The pilot randomisedcontrolled NOH-PE trial. Thromb Haemost.
2011 Dec; 106(6): 1053-61.141. Guzin K, Tomruk S, Tuncay YA, Naki M, Sezginsoy S, Zemheri E, YucelN, Kanadikirik F. The relation of increased uterine artery blood flow resistance and324impaired trophoblast invasion in pre-eclamptic pregnancies. Arch Gynecol Obstet.2005; 272: 283–288.142. Hafner E, Metzenbauer M, Höfinger D, Stonek F, Schuchter K, Waldhör T,Philipp K.
Comparison between three-dimensional placental volume at 12 weeksand uterine artery impedance/notching at 22 weeks in screening for pregnancyinduced hypertension, pre-eclampsia and fetal growth restriction in a low-riskpopulation. Ultrasound Obstet Gynecol. 2006 Jun;27(6):652-7.143. Hammer ES, Cipolla MJ.Cerebrovascular Dysfunction in PreeclampticPregnancies.
Curr Hypertens Rep. 2015 Aug;17(8):64.144. Harrington K, Goldfrad C, Carpenter RG, Campbell S. Transvaginal uterineand umbilical artery Doppler examination of 12-16 weeks and the subsequentdevelopment of pre-eclampsia and intrauterine growth retardation. UltrasoundObstet Gynecol. 1997;2:94–100.145. Hayman R, Warren A, Brockelsby J, John- son I, Baker P. Plasma fromwomen with pre-eclampsia induces an in vitro alteration in the endotheliumdependent behaviour of myometrial resistance arteries. BJOG: An InternationalJournal of Obstetrics & Gynaecology. 2000;107: 108–115.146.
Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release ofglial tissue-specific proteins after acute stroke: A comparative analysis of serumconcentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 2000Nov;31(11):2670-7.147. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L,Muller DN, Luft FC, Staff AC. Dysregulation of the Circulating and Tissue-BasedRenin-Angiotensin System in Preeclampsia. Hypertension. 2007;49:604–611.148.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
